# Sentinel Node Detection in Endometrial Cancer: A Consolidation Study on Detection Rates of Metastatic Disease

> **NCT03838055** · NA · UNKNOWN · sponsor: **Region Skane** · enrollment: 362 (estimated)

## Conditions studied

- Sentinel Lymph Node
- Endometrial Cancer
- Lymphedema

## Interventions

- **PROCEDURE:** Injection of tracer ( ICG) and detection of sentinel lymph nodes

## Key facts

- **NCT ID:** NCT03838055
- **Lead sponsor:** Region Skane
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02
- **Primary completion:** 2022-12
- **Final completion:** 2023-12
- **Target enrollment:** 362 (ESTIMATED)
- **Last updated:** 2019-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03838055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03838055, "Sentinel Node Detection in Endometrial Cancer: A Consolidation Study on Detection Rates of Metastatic Disease". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03838055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
